These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 30562637)
1. Methylation of gene CHFR promoter in acute leukemia cells. Gong H; Liu W; Zhou J; Xu H J Huazhong Univ Sci Technolog Med Sci; 2005; 25(3):240-2. PubMed ID: 16201259 [TBL] [Abstract][Full Text] [Related]
2. Genome-wide DNA methylation status is a predictor of the efficacy of anti-EGFR antibodies in the second-line treatment of metastatic colorectal cancer: Translational research of the EPIC trial. Ouchi K; Takahashi S; Sasaki K; Yoshida Y; Taniguchi S; Kasahara Y; Komine K; Imai H; Saijo K; Shirota H; Takahashi M; Ishioka C Int J Colorectal Dis; 2024 Jun; 39(1):89. PubMed ID: 38862615 [TBL] [Abstract][Full Text] [Related]
3. CHFR: a key checkpoint component implicated in a wide range of cancers. Sanbhnani S; Yeong FM Cell Mol Life Sci; 2012 May; 69(10):1669-87. PubMed ID: 22159584 [TBL] [Abstract][Full Text] [Related]
4. Nuclear localization of Chfr is crucial for its checkpoint function. Kwon YE; Kim YS; Oh YM; Seol JH Mol Cells; 2009 Mar; 27(3):359-63. PubMed ID: 19326084 [TBL] [Abstract][Full Text] [Related]
5. Structural basis of poly(ADP-ribose) recognition by the multizinc binding domain of checkpoint with forkhead-associated and RING Domains (CHFR). Oberoi J; Richards MW; Crumpler S; Brown N; Blagg J; Bayliss R J Biol Chem; 2010 Dec; 285(50):39348-58. PubMed ID: 20880844 [TBL] [Abstract][Full Text] [Related]
6. Germline variation in colorectal risk Loci does not influence treatment effect or survival in metastatic colorectal cancer. Sanoff HK; Renfro LA; Poonnen P; Ambadwar P; Sargent DJ; Goldberg RM; McLeod H PLoS One; 2014; 9(4):e94727. PubMed ID: 24727911 [TBL] [Abstract][Full Text] [Related]
7. Real-world data on sequencing third-line therapies for metastatic colorectal cancer. Bekaii-Saab TS Clin Adv Hematol Oncol; 2024 Jun; 22 Suppl 4(5):10-14. PubMed ID: 38805299 [No Abstract] [Full Text] [Related]
8. How best to extend overall survival in metastatic colorectal cancer: Q&A. Bekaii-Saab TS; Barzi A; Cusnir M Clin Adv Hematol Oncol; 2024 Jun; 22 Suppl 4(5):16-17. PubMed ID: 38805301 [No Abstract] [Full Text] [Related]
9. A Phase II Study Alternating Erlotinib With Second-line mFOLFOX6 or FOLFIRI for Metastatic Colorectal Cancer. Kearney MR; Chen EY; Vaccaro GM; Strother J; Burt A; Todd K; Donovan J; Kampa-Schittenhelm KM; Lopez CD Anticancer Res; 2019 Jan; 39(1):245-252. PubMed ID: 30591465 [TBL] [Abstract][Full Text] [Related]
10. CHFR promotes metastasis of human gastric carcinoma by activating AKT and ERK via NRF2- ROS axis. He F; Ye B; Wu X; Pan J; Wang J; Wang X BMC Gastroenterol; 2023 Apr; 23(1):114. PubMed ID: 37024798 [TBL] [Abstract][Full Text] [Related]
11. Epigenetic insights in the diagnosis, prognosis, and treatment selection in CRC, an updated review. Ghadiri Moghaddam F; Farajnia S; Karbalaei-Mahdi M; Monir L Mol Biol Rep; 2022 Oct; 49(10):10013-10022. PubMed ID: 35727475 [TBL] [Abstract][Full Text] [Related]
12. Deciphering CHFR Role in Pancreatic Ductal Adenocarcinoma. González-Borja I; Alors-Pérez E; Amat I; Alonso L; Viyuela-García C; Goñi S; Reyes JC; Ceballos-Chávez M; Hernández-García I; Sánchez-Frías ME; Santamaría E; Razquin S; Arjona-Sánchez Á; Arrazubi V; Pérez-Sanz J; Vera R; Fernández-Irigoyen J; Castaño JP; Viúdez A Front Med (Lausanne); 2021; 8():720128. PubMed ID: 34869418 [TBL] [Abstract][Full Text] [Related]
13. Epigenetic Alterations Upstream and Downstream of p53 Signaling in Colorectal Carcinoma. Tomicic MT; Dawood M; Efferth T Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439227 [TBL] [Abstract][Full Text] [Related]
14. Integrative omics analysis reveals effective stratification and potential prognosis markers of pan-gastrointestinal cancers. Jiangzhou H; Zhang H; Sun R; Fahira A; Wang K; Li Z; Shi Y; Wang Z iScience; 2021 Aug; 24(8):102824. PubMed ID: 34381964 [TBL] [Abstract][Full Text] [Related]